Traws Pharma (TRAW) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to -$6.4 million.
- Traws Pharma's Enterprise Value fell 1866.91% to -$6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.4 million, marking a year-over-year decrease of 1866.91%. This contributed to the annual value of -$21.3 million for FY2024, which is 248.31% down from last year.
- As of Q3 2025, Traws Pharma's Enterprise Value stood at -$6.4 million, which was down 1866.91% from -$13.1 million recorded in Q2 2025.
- In the past 5 years, Traws Pharma's Enterprise Value ranged from a high of -$5.4 million in Q3 2024 and a low of -$59.4 million during Q3 2021
- Moreover, its 5-year median value for Enterprise Value was -$29.7 million (2023), whereas its average is -$31.1 million.
- As far as peak fluctuations go, Traws Pharma's Enterprise Value tumbled by 18946.12% in 2021, and later skyrocketed by 7856.92% in 2024.
- Quarter analysis of 5 years shows Traws Pharma's Enterprise Value stood at -$55.1 million in 2021, then rose by 29.62% to -$38.8 million in 2022, then skyrocketed by 46.28% to -$20.8 million in 2023, then dropped by 2.48% to -$21.3 million in 2024, then skyrocketed by 69.91% to -$6.4 million in 2025.
- Its last three reported values are -$6.4 million in Q3 2025, -$13.1 million for Q2 2025, and -$15.9 million during Q1 2025.